When comparing patients with ER-positive/HER2-positive breast cancer, male patients had higher alterations in ERBB2, PIK3CA, GATA3, and MDM2 genes while female patients had higher alterations in TP53 genes. This evidence concerns the gene GATA3 and breast carcinoma.